Obesity is a term that means you weigh at least 20% more than what is considered abnormal weight for your height. Extra weight makes you more likely to have high blood pressure and high cholesterol. Both of those conditions make heart disease or stroke more likely.Obesity can also affect your quality of life and lead to psychological problems, such as low self-esteem or depression.Taking steps to tackle obesity is important because, in addition to causing obvious physical changes.
Most drugs developed to
treat obesity have focused on reducing appetite by manipulating signals in the
gastrointestinal tract or central nervous system. These approaches have had
limited success, and sometimes produce problematic side effects—the appetite
suppressant sibutramine, for example, was pulled from the market in 2010
because it increased patients’ risk of strokes and heart attacks
Controlling metabolism and
immune responses by directly targeting fat cells, or adipocytes, is a more
attractive strategy, but has been hampered by an inability to precisely and
effectively deliver small molecules to adipose tissue. Previous attempts at
gene therapy in adipocytes have employed viral vectors, which have led to
unchecked expression with potentially harmful effects.
Researchers produced a molecular complex
containing ATS oligopeptides bound to expression vectors for a short-hairpin
RNA directed against the FABP4 gene,
which encodes a fatty acid binding protein that affects lipid storage in
adipocytes. When the researchers injected this complex into mice on a high-fat
diet, they saw a 20 percent decrease in body weight, as well as improved
glucose tolerance and insulin sensitivity, after seven weeks of treatment.
A specific short peptide
aimed at fat cells can deliver a DNA sequence that knocks down expression of a
key fatty acid binding protein. The method provides a new way to study the functions of adipocytes—a notoriously
intractable cell type—and suggests an avenue for gene therapy to combat obesity
in humans.
with love
-Dixy
No comments:
Post a Comment